FDA Authorizes Shelf Life Extension of Janssen/Johnson & Johnson COVID-19 Vaccine
The extension was based on data from ongoing stability assessment studies.
The extension was based on data from ongoing stability assessment studies.
The researchers’ objective was to investigate whether racial/ethnic minority groups, women, and older adults are underrepresented among participants in vaccine clinical trials.
The expanded EUA of the COVID-19 vaccine “will be the biggest positive change for adolescents since the beginning of the lockdown in March 2020.”
— Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Investigators assessed if healthcare workers with previous SARS-CoV-2 infections mount better responses to a single dose of an mRNA vaccine than those without previous infection.
Study authors analyzed data from Israel’s largest health care organization to evaluate the effectiveness of Pfizer’s COVID-19 mRNA vaccine, BNT162b2, in a real world setting.